An important finding has been made by McMaster researchers about Fragile X Syndrome (FXS), a sex-linked genetic disorder that affects approximately one in 4,000 males and one in 6,000 females.
FXS is the most common genetic disorder associated with mental impairment. The affected gene (FMR1) leads to inactivation of the FMR1 gene product, known as the fragile X mental retardation protein (FMRP).
Brain development in the absence of this protein leads to cognitive effects, learning and memory problems, attention deficit, hyperactivity and autistic behaviors. Many children go undiagnosed with Fragile X.
Although the exact functions of FMRP in the brain are unresolved, there is compelling evidence that FMRP is important for normal function at the sites of communication between cells or neurons in the brain. Until now, FMRP was thought to be found only in neurons.
Stem cells are candidates for cell therapy in neurological disorders since they are capable of producing all cell types in the nervous system.
When studying the development of adult stem cells from the mouse brain, Laura Pacey, a Ph.D. student in professor Laurie Doering’s laboratory, realized that cells, in addition to neurons, were also producing the FMRP. Doering is an associate professor in the Department of Pathology and Molecular Medicine.
Using specific markers to identify cell types, it was apparent that another major class of cells, called glial cells, also contained FMRP. Glial cells provide structural and metabolic support for neurons and they are necessary for normal function of the nervous system.
This discovery is important because these neuro-glial cells (astrocytes) play important roles in the development and maintenance of normal communication between neurons in the brain and spinal cord. So the absence of FMRP in astrocytes may contribute to the abnormal neuronal structures seen in the brains of Fragile X patients. The results of this research have strong implications for the cellular causes of FXS and will open new streams of research.
“This is an unexpected finding” states Doering. “Like fitting a piece of a puzzle that suddenly paints the main picture in a different perspective. We have another major cell type as a focus in Fragile X research. It will supply needed insight on the biology causing Fragile X and help to strengthen the potential for treatment strategies”.
Source: McMaster University
Related stories:
Mechanism may explain aspects of brain impairment seen in Fragile X Syndrome
Scientists report that a protein associated with a common form of mental retardation plays an important role in intracellular trafficking within neurons. The research, published by Cell Press in the June issue of the journal
Developmental Cell, reveals new information about how neuronal communication and plasticity are affected in Fragile X Syndrome (FXS).
Scientists identify fundamental brain defect, probable drug target in fragile X syndrome
Scientists have discovered how the gene mutation responsible for fragile X syndrome--the most common inherited form of mental retardation--alters the way brain cells communicate. In neurons cultured from laboratory rats, the scientists also were able to reverse the effects of the mutation using a drug targeted to the specific site in an upstream pathway of the defect. The finding could lead to the development of human therapies for this previously untreatable condition.
Crucial progress in understanding Fragile X mental retardation protein
Researchers in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine have identified a new regulatory target for the Fragile X mental retardation protein (FMRP), laying the groundwork for possible new treatments for Fragile X syndrome(FXS), the leading inherited form of mental retardation.
Bone marrow-derived stem cells may offer novel therapeutic option for skin disorder
Stem cells derived from bone marrow may serve as a novel therapeutic option to treat a disease called epidermolysis bullosa (EB), a disorder characterized by extraordinarily fragile skin, according to a study prepublished online in
Blood, the official journal of the American Society of Hematology.
Opening up the last part of the spectrum
(PhysOrg.com) -- New European research on the last, hidden part of the electromagnetic spectrum is producing new, safe and non-destructive tests for medicine, security and industrial quality control.
It takes guts to build bone, Columbia scientists discover
(PhysOrg.com) -- Bone growth is controlled in the gut through serotonin, the same naturally present chemical used by the brain to influence mood, appetite and sleep, according to a new discovery from researchers at Columbia University Medical Center. Until now, the skeleton was thought to control bone growth, and serotonin was primarily known as a neurotransmitter acting in the brain. This new insight could transform how osteoporosis is treated in the future by giving doctors a way to increase bone mass, not just slow its loss. Findings are reported in the Nov. 26, 2008 issue of
Cell.
Scientists create 'good bugs' to fight 'bad bugs'
For years, you've been able to walk into a drugstore or health food outlet and buy a host of "probiotics" - natural dietary supplements such as Acidophilus or Lactinex - off the shelf to treat conditions such as children's eczema or traveler's diarrhea.
Capturing replication strategies used by SARS viruses in their bid to spread
Just over five years ago, an outbreak of severe acute respiratory syndrome (SARS)-coronavirus killed over 750 people. SARS (corona)virus, a positive-stranded RNA virus, replicates in the cytoplasm of host cells, attaching its replication complex to intracellular membranes that it has modified for this purpose.